Who are Windtree Therapeutics, Inc.'s main suppliers?

Windtree Therapeutics, Inc. (WINT) key suppliers include: VARIAN-BIOPHARMACEUTICALS-INC, Evofem Biosciences, Inc., Evofem Biosciences, Inc., OBNB, ORANY and 2 more. View the full supplier network at chainsifter.com/chain/WINT.

Who are Windtree Therapeutics, Inc.'s major customers?

Windtree Therapeutics, Inc. (WINT) key customers include: Evofem Biosciences, Inc., Evofem Biosciences, Inc., SEVEN-KNOTS-LLC, ORANY, ORANY and 2 more. View the full customer network at chainsifter.com/chain/WINT.

What sector is Windtree Therapeutics, Inc. in?

Windtree Therapeutics, Inc. (WINT) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Windtree Therapeutics, Inc. Suppliers, Customers & Supply Chain (WINT)

7Suppliers

7Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Windtree Therapeutics, Inc. (WINT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

17Total relationships

3Distinct source URLs

7High confidence

0.784Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Windtree Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
VARIAN-BIOPHARMACEUTICALS-INC	VARIAN-BIOPHARMACEUTICALS-INC	92%	Pursuant to the Asset Purchase Agreement, we purchased all of the assets of Varian’s business associated with a license agreement...
EVFM	Evofem Biosciences, Inc.	72%	Reciprocal relationship from EVFM graph: Reciprocal relationship from WINT graph: rsuant to the terms of the warrant agreement, the exercise price of the July 2024 Warrants originally issued in conne…
EVFM	Evofem Biosciences, Inc.	72%	rsuant to the terms of the warrant agreement, the exercise price of the July 2024 Warrants originally issued in connection with the Series C Preferred Stock was reduced to $ effective January 24, 202…
OBNB	OBNB	72%	Reciprocal relationship from OBNB graph: Reciprocal relationship from WINT graph: Reciprocal relationship from OBNB graph: Reciprocal relationship from WINT graph: Reciprocal relationship from OBNB g…
ORANY	ORANY	72%	Track or Breakthrough Therapy designation or other expedited programs. These designations and programs are intended to facilitate and expedite development and review of a New Drug Application, or NDA…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from WINT graph: Track or Breakthrough Therapy designation or other expedited programs. These designations and programs are intended …
WINTW	WINDTREE THERAPEUTICS INC C/WTS	72%	Reciprocal relationship from WINTW graph: . The accompanying condensed consolidated financial statements reflect the 1 -for- 18 reverse split of our common stock that was approved by our Board of Dir…

Windtree Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
EVFM	Evofem Biosciences, Inc.	90%	Reciprocal relationship from EVFM graph: Reciprocal relationship from WINT graph: Reciprocal relationship from EVFM graph: Reciprocal relationship from WINT graph: we will act as the supplier to Evof…
EVFM	Evofem Biosciences, Inc.	90%	we will act as the supplier to Evofem of its Phexxi® product outside of the United States
SEVEN-KNOTS-LLC	SEVEN-KNOTS-LLC	90%	we may sell shares of common stock to Seven Knots from time to time
ORANY	ORANY	72%	Track or Breakthrough Therapy designation or other expedited programs. These designations and programs are intended to facilitate and expedite development and review of a New Drug Application, or NDA…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from WINT graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from WINT graph: Track or Breakthrough Therapy des…
CVIE-THERAPEUTICS-LIMITED	CVIE-THERAPEUTICS-LIMITED	62%	30, 2025 . The fair value of the June 2025 Warrants on the dates of issuance was $2.9 million. The June 2025 Warrants are considered permanent equity and do not need to be remeasured. Given the fair …
DEERFIELD-MANAGEMENT-COMPANY	DEERFIELD-MANAGEMENT-COMPANY	62%	30, 2025 . The fair value of the June 2025 Warrants on the dates of issuance was $2.9 million. The June 2025 Warrants are considered permanent equity and do not need to be remeasured. Given the fair …

Windtree Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
WINT-DEBT-13569	Warrants outstanding: 6	90%	xbrl warrant detail from xbrl 2024-12-31.
WINT-DEBT	Debt stack $25.0M	90%	Market cache reports total debt of $25.0M.
WINT-DEBT-13570	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.

Windtree Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Windtree Therapeutics, Inc..

Windtree Therapeutics, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Windtree Therapeutics, Inc..

Windtree Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
OBNB	Osprey BNB Chain Trust	100.00	1	['supplier']
WINTW	WINDTREE THERAPEUTICS INC C/WTS	100.00	1	['supplier']
ORANY	ORANGE	100.00	1	['customer', 'supplier']
EVFM	Evofem Biosciences, Inc.	100.00	1	['customer', 'supplier']
ASBPW	Aspire Biopharma Holdings, Inc.	50.00	2
BFRGW	BullFrog AI Holdings, Inc.	50.00	2
BCDRF	Banco Santander, S.A.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
BLTE	Belite Bio, Inc	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
ARQQW	Arqit Quantum Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
CMCM	Cheetah Mobile Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
BFRIW	Biofrontera Inc.	50.00	2
CINGW	Cingulate Inc.	50.00	2
EPDU	ENTERPRISE PRODUCTS PARTNERS L.P.	50.00	2
BNBX	BNB Plus Corp.	50.00	2
D	Dominion Energy, Inc.	50.00	2

Windtree Therapeutics, Inc. Supply Chain